ACTIVE

Inteliphage

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-2 M €
-81.2% YoY
Revenue
22,5 k €
Equity
3,2 M €
+96.5% YoY
Workforce
16,1 ETP
+33.1% YoY

What does Inteliphage do?

Inteliphage is a Private limited company incorporated in 2018. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Ottignies-Louvain-la-Neuve. It employs on average 16,1 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0692.975.522
Incorporation
27/03/2018
Legal form
Private limited company
Registered office
Avenue Jean Monnet 1
1348 Ottignies-Louvain-la-Neuve · WallonieSee on map
Contributed capital
3 877 730,00 €
Latest accounts
31/12/2025
Average workforce
16,1 ETP
Activities (NACE)
21100Manufacture of basic pharmaceutical products· main21100Manufacture of basic pharmaceutical products47730Dispensing chemist in specialised stores47730Dispensing chemist in specialised stores47730Dispensing chemist in specialised stores47730Dispensing chemist in specialised stores
Joint committees (1)
  • 207
Signals
Good liquidityHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232022202120202019
Income statement
Revenue22,5 k €––––5 k €105,7 k €
EBITDA-1,7 M €-952,5 k €-1,4 M €-673,3 k €-364,7 k €5,3 k €-1,3 k €
Operating result-1,9 M €-1,1 M €-1,5 M €-719,6 k €-364,7 k €5,3 k €-1,3 k €
Net result-2 M €-1,1 M €-1,6 M €-752,2 k €-365,9 k €5,1 k €-1,5 k €
Balance sheet
Equity3,2 M €1,6 M €1,6 M €-834,5 k €-356,2 k €9,7 k €4,7 k €
Total assets12,6 M €7,8 M €5,5 M €2,7 M €990,3 k €11,4 k €33,4 k €
Cash597,2 k €242,7 k €124,5 k €134,6 k €931,6 k €5 k €1,5 k €
Debts9,5 M €6,2 M €3,9 M €3,4 M €1,3 M €1,6 k €28,7 k €
Other
Workforce16,1 ETP12,1 ETP–––––
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 11 ended

Active mandates

Sylvie Rauel

Director · since 24 décembre 2025

Active
Anjac SAS

Director · since 02 septembre 2025

Represented by Emmanuelle Raillard-Labbé

Active
CENTIVIA

Managing director · since 23 juin 2025

Represented by Charles Perrard

Active
Emmanuel Caeymaex

Chairman of the board of directors · since 23 juin 2025

Active

Ended mandates

Emmanuel Caeymaex

Director · since 02 mai 2024

Ended
Anjac SAS SA

Director · since 29 juin 2023

Represented by Trippltelli SOPHIE

Ended
Gunther Vanwezer

Managing director · since 29 juin 2023

Ended
Guillaume de Viron

Director · since 08 février 2022

Ended
At this address

Other companies at this address

CompanyCBE no.
AIR VISION● Active
0466.468.644
ARK Capture Solutions● Active
1009.117.031
Bâtisseurs d'Etoiles● Active
0763.364.660
BETA Systems Software● Active
0460.900.052
Charmoz Invest● Active
1025.992.754
CHEMIUM● Active
0640.872.565
ChemoSensoryX Biosciences SA● Active
0867.817.428
DNAlytics● Active
0844.973.235
FEMAG● Active
0566.972.126
GO-PME● Active
0717.854.636
HEXION RESEARCH BELGIUM SA● Active
0469.529.092
LAPORTE EURO● Active
0767.819.732
Logstail Belgium● Active
1036.995.128
MINAGRO● Active
0739.988.353
SABCA Technologies● Active
0790.626.214
SiPulse● Active
1040.681.722
SUNSWITCH● Bankrupt
0890.449.112
Venturi Holding● Active
1029.462.879
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date13/07/202624/10/202527/11/202422/11/202310/10/202230/08/2021
General meeting29/06/202617/09/202507/11/202412/09/202324/08/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

7 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/06/202613/07/2026FrenchPDF
Abridged model31/12/202417/09/202524/10/2025FrenchPDF
Micro model31/12/202307/11/202427/11/2024FrenchPDF
Micro model31/12/202212/09/202322/11/2023FrenchPDF
Micro model31/12/202124/08/202210/10/2022FrenchPDF
Micro model31/12/202007/06/202130/08/2021FrenchPDF
Micro model31/12/201902/06/202031/08/2020FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 11 ended

Active mandates

Sylvie Rauel

Director · since 24 décembre 2025

Active
Anjac SAS

Director · since 02 septembre 2025

Represented by Emmanuelle Raillard-Labbé

Active
CENTIVIA

Managing director · since 23 juin 2025

Represented by Charles Perrard

Active
Emmanuel Caeymaex

Chairman of the board of directors · since 23 juin 2025

Active

Ended mandates

Emmanuel Caeymaex

Director · since 02 mai 2024

Ended
Anjac SAS SA

Director · since 29 juin 2023

Represented by Trippltelli SOPHIE

Ended
Gunther Vanwezer

Managing director · since 29 juin 2023

Ended
Guillaume de Viron

Director · since 08 février 2022

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates10/02/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/01/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates12/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/01/2025
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/05/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/05/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates21/09/2023
    DIVERS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/07/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DENOMINATION - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-2 M €↓
  2. 2024
    Annual accounts 2024-1,1 M €↑
  3. 2024
    Name changeInteliphage
  4. 2023
    Annual accounts 2023-1,6 M €↓
  5. 2022
    Annual accounts 2022-752,2 k €↓
  6. 2022
    Name changeInteliphage (anciennement Vesale Bioscience)
  7. 2021
    Annual accounts 2021-365,9 k €↓
  8. 2021
    Name changeVésale Bioscience
  9. 2020
    Annual accounts 20205,1 k €↑
  10. 2019
    Annual accounts 2019-1,5 k €
  11. 27/03/2018
    IncorporationPrivate limited company